DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

Express Scripts (NASDAQ: ESRX)



company name or ticker
Company Photos
(Click to zoom)

This is Why Diabetes Treatment Costs Are Soaring

A new class of diabetes drugs is driving up the cost of diabetes medicine.

The Best Upcoming Dividend Stocks

Friday's ETF with Unusual Volume: XHS

Why Rite Aid Is A Compelling Long-Term Pick In The Pharmacy Space

Analyzing Steven Romick's New Buys: Express Scripts (ESRX)

Why Esperion Therapeutics, Inc. is Sky-Rocketing Higher

Esperion Therapeutics, Inc. is raising money to fund development of its cholesterol lowering drug ETC-1002.

Zacks Industry Outlook Highlights: Orexigen, MannKind, Amgen, Medivation and Express Scripts - Press

Zacks Industry Outlook Highlights: Orexigen, MannKind, Amgen, Medivation and Express Scripts - Press Releases

Regeneron Pharmaceuticals: Some Uncertainty Near Term, But Maintaining My Bullish Outlook

Illustrating Why Amgen Offers Additional Alpha Versus Gilead Sciences

3 Stocks Benefiting From Jaw-Dropping Growth in Specialty Drug Spending

Spending on specialty drugs soared 31% last year, boosting sales at Gilead Sciences, Celgene Corporation, and AbbVie Inc.
See More Articles...